Absence from school · healthy, community‐dwelling children older than 2 years of age
It is very uncertain whether inactivated influenza vaccine changes absence from school compared with placebo or do nothing (very low certainty).
1 finding from 1 review
Number of parents having to take off work during · healthy, community‐dwelling children older than 2 years of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Hospitalisation ‐ not reported · healthy, community‐dwelling children older than 2 years of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Fever ‐ not reported · healthy, community‐dwelling children older than 2 years of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Nausea ‐ not reported · healthy, community‐dwelling children older than 2 years of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Otitis media · healthy, community‐dwelling children younger than 16 years of age
Live attenuated influenza vaccine showed no clear difference in otitis media assessed by clinical confirmation (inspection of ear… compared with placebo or do nothing (moderate certainty).
1 finding from 1 review
Number of children with time off from school during · healthy, community‐dwelling children younger than 16 years of age
It is very uncertain whether live attenuated influenza vaccine changes number of children with time off from school during compared with placebo or do nothing (very low certainty).
1 finding from 1 review
Number of parents having to take off work during · healthy, community‐dwelling children younger than 16 years of age
Live attenuated influenza vaccine showed no clear difference in number of parents having to take off work during compared with placebo or do nothing (low certainty).
1 finding from 1 review
Hospitalisation ‐ not reported · healthy, community‐dwelling children younger than 16 years of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Fever · healthy, community‐dwelling children younger than 16 years of age
1 finding from 1 review
Nausea ‐ not reported · healthy, community‐dwelling children younger than 16 years of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Maternal death · Pregnant women aged 18 to 38 years and an estimated gestation of 20 to 36 weeks.
Viral influenza vaccine showed no clear difference in maternal death compared with control (moderate certainty).
1 finding from 1 review
Infant death (up to 175 days) · Pregnant women aged 18 to 38 years and an estimated gestation of 20 to 36 weeks.
Viral influenza vaccine showed no clear difference in infant death (up to 175 days) compared with control (moderate certainty).
1 finding from 1 review
Perinatal death (stillbirth + death in first week of life) · Pregnant women aged 18 to 38 years and an estimated gestation of 20 to 36 weeks.
Viral influenza vaccine showed no clear difference in perinatal death (stillbirth + death in first week of life) compared with control (moderate certainty).
1 finding from 1 review
Any respiratory illness in women · Pregnant women aged 18 to 38 years and an estimated gestation of 20 to 36 weeks.
Viral influenza vaccine showed no clear difference in any respiratory illness in women compared with control (high certainty).
1 finding from 1 review
Any respiratory illness in infants · Pregnant women aged 18 to 38 years and an estimated gestation of 20 to 36 weeks.
Viral influenza vaccine showed no clear difference in any respiratory illness in infants compared with control (high certainty).
1 finding from 1 review
Maternal hospitalisation for any infection · Pregnant women aged 18 to 38 years and an estimated gestation of 20 to 36 weeks.
Viral influenza vaccine showed no clear difference in maternal hospitalisation for any infection compared with control (moderate certainty).
1 finding from 1 review
Neonatal hospitalisation due to sepsis within 28 days of birth · Pregnant women aged 18 to 38 years and an estimated gestation of 20 to 36 weeks.
Viral influenza vaccine showed no clear difference in neonatal hospitalisation due to sepsis within 28 days of birth compared with control (moderate certainty).
1 finding from 1 review
Free influenza vaccine compared to invitation to be vaccinated but patient pays · people aged 60 years and older living in the community
Enhancing vaccination access leads to higher free influenza vaccine compared to invitation to be vaccinated but… compared with no intervention or another intervention (high certainty).
1 finding from 1 review
Free influenza vaccine compared to no intervention · people aged 60 years and older living in the community
1 finding from 1 review